• ‘We are excited’: Why this ASX mining stock is rocketing 14%

    Rincon Resources Ltd (ASX: RCR) shares are among the best performers on the market on Wednesday.

    In morning trade, the ASX mining stock is up a sizeable 14% to 12 cents.

    Why is this ASX mining stock rocketing?

    The catalyst for this strong gain has been the release of an announcement from the mineral exploration company today.

    According to the release, Rincon Resources has received aboriginal heritage clearance for drilling activities to commence at the West Arunta Project in Western Australia.

    The ASX mining stock will now be able to drill its high-priority Avalon niobium and rare earth elements (Nb-REE) target, as well as the Sheoak, K1, and K2 targets.

    Management is particularly positive about its Avalon gravity anomaly. It highlights that the anomaly is comparable in size to the one underlying the Luna deposit owned, which is owned by WA1 Resources Ltd (ASX: WA1). That deposit was recently confirmed as the most significant niobium discovery globally in over 70 years with an inferred mineral resource estimate of 200Mt @ 1.00% Nb2O5.

    Rincon Resources has planned an initial 3,000m diamond drilling/reverse circulation (DD/RC) drill program to primarily test the source of the Avalon gravity target. It will also test the 3 km lateral extent of weathered zone where potential niobium enrichment may be present.

    Drilling is set to begin in the middle of July following the completion of site works. These activities will be supported by a recent $5.6 million capital raising.

    ‘We are excited’

    The ASX mining stock’s managing director, Gary Harvey, revealed that the company was excited to start its drilling activities. He said:

    We are excited to commence drilling at our Avalon target, which we interpret as a potential carbonatite intrusion with niobium and rare earth element (Nb-REE) enrichment in the upper weathered profile. The size and characteristics of the Avalon anomaly, compared to recent significant discoveries in the region, heighten our anticipation for this program.

    The Luni discovery by WA1 Resources has demonstrated the potential for world-class niobium deposits in the West Arunta region. With Avalon’s comparable size, we are eager to explore its full potential. With $5.6 million recently raised, our strong financial position enables us to aggressively pursue these opportunities and potentially extend our initial program should positive results warrant it.

    Following today’s gain, this mining stock has now doubled in value over the last 12 months. Though, it still only has a market capitalisation of approximately $34 million.

    The post ‘We are excited’: Why this ASX mining stock is rocketing 14% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Wa1 Resources right now?

    Before you buy Wa1 Resources shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wa1 Resources wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Is Nvidia stock going to $144?

    A woman holds a soldering tool as she sits in front of a computer screen while working on the manufacturing of technology equipment in a laboratory environment.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Nvidia (NASDAQ: NVDA) share prices have recently reversed course after seemingly pushing higher for months without a breather. The stock now trades nearly 13% off its intraday high price of over $140 per share hit last month.

    There is one Wall Street analyst who thinks shares of the artificial intelligence (AI) leader will soon rebound and even exceed its all-time high. Morgan Stanley analyst Joseph Moore put out a new note on Nvidia on Monday increasing his price target from $116 to $144 per share. Moore determined that share price based on what he sees as a jump in earnings per share (EPS) through next year. Moore thinks Nvidia stock is worth buying as his new price target would represent a gain of about 17.5% from its current price.

    Nvidia’s “compelling narrative”

    After data checks pointed to strong demand in China and Taiwan, as well as the U.S., Moore raised his EPS estimate for the semiconductor giant from $2.94 to $3.34 per share for next year. Moore believes Nvidia, “remains the most compelling narrative in the AI [semiconductor] space, and as we transition from H100 to H200 and then Blackwell, visibility and backlog will improve materially.”

    That last point is the key to an investment in Nvidia right now. Even after its recent correction, Nvidia shares had run up ahead of revenue and earnings growth. In other words, further growth is already built into the stock price to some extent.

    But even as Nvidia prepares to begin bulk shipments of its new, Blackwell AI platform, its H100 and H200 graphics processing units (GPUs) are still in high demand. That’s because many of Nvidia’s customers have been waiting in line to get these high-strength computing chips needed for training generative AI models.

    Those sales will remain strong even as shipments of the new Blackwell chip accelerate. That’s why investors should still feel comfortable buying Nvidia shares. Even after the massive gains, there is a strong base of sales, and an even stronger pipeline of new AI products ahead.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    The post Is Nvidia stock going to $144? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Nvidia right now?

    Before you buy Nvidia shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Nvidia wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks *Returns as of 24 June 2024

    More reading

    Howard Smith has positions in Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Nvidia. The Motley Fool Australia has recommended Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Guess which ASX mining stock is jumping 8% on deal with Mitsubishi

    Chalice Mining Ltd (ASX: CHN) shares are catching the eye on Wednesday.

    In morning trade, the ASX mining stock is up 8% to $1.64.

    Why is this ASX mining stock racing higher?

    Investors have been scrambling to buy the company’s shares this morning after it made a big announcement.

    According to the release, Chalice Mining and Mitsubishi Corporation have entered into a non-binding memorandum of understanding (MOU).

    Mitsubishi is one of Japan’s largest conglomerates and a leading global natural resources investor. Management notes that it has a long and successful track record of partnering with mining companies to fund and develop major mining projects globally. As a result, it is considered a tier-one strategic partner.

    What is the MOU?

    This MOU will see the parties work together with the intention of forming a potential strategic partnership to develop the ASX mining stock’s 100%-owned Gonneville PGE-Nickel-Copper-Cobalt Project in Western Australia.

    Management notes that the agreement establishes a general framework for collaboration on technical, financing, marketing, and offtake aspects of the project during the ongoing pre-feasibility study (PFS).

    It also highlights that Mitsubishi brings a broad range of capabilities, experience and relationships across equity and debt financing, product marketing, procurement and large-scale project development.

    The MOU is non-exclusive and does not restrict the ASX mining stock from entering into any other transaction involving the project.

    A foundational, long-term relationship

    Chalice Mining’s managing director and CEO, Alex Dorsch, was very pleased with the news. He said:

    We are very pleased to have executed the MOU with Mitsubishi, which marks the beginning of a foundational, long-term relationship. Mitsubishi’s involvement in the Gonneville Project follows extensive due diligence and discussions over the past ~12 months and highlights the longer-term strategic nature and value of the Project as a potential large-scale, long-life and low-carbon source of critical minerals for Western markets.

    From the outset of the strategic process, Mitsubishi was always considered one of the most impressive and best suited strategic partners for the Gonneville Project, based on its decades-long development, operational and trading track record. In the context of key ongoing PFS workstreams and optimisations, the MOU structure is favourable, as it provides a framework for collaboration for both parties during the PFS and allows for the progression and de-risking of the Project prior to having good faith discussions around a potential joint arrangement and investment following the completion of the PFS.

    Despite today’s gain, this ASX mining stock is still down ~73% over the past 12 months.

    The post Guess which ASX mining stock is jumping 8% on deal with Mitsubishi appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Chalice Gold Mines Limited right now?

    Before you buy Chalice Gold Mines Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Chalice Gold Mines Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • A new twist in Apple’s deal with OpenAI

    OpenAI logo with text that says GPT-5 behind a person holding a phone
    Apple gets an observer role on OpenAI's board as part of the companies' partnership, per Bloomberg.

    • Apple gets an observer role on OpenAI's board as part of the companies' partnership, per Bloomberg.
    • The arrangement raises Apple to Microsoft's level within the AI startup, according to the outlet.
    • Phil Schiller, head of Apple's app store, was reportedly picked for the position.

    Apple scored a board observer seat as part of its landmark deal with the AI giant, Bloomberg reported Tuesday, citing people familiar with the matter.

    According to the outlet, the arrangement puts Apple on equal footing with OpenAI's biggest backer, Microsoft, raising new questions about how the competitors will coexist on OpenAI's board.

    Details of the new arrangement follow Apple's announcement last month that it would integrate OpenAI's ChatGPT with future devices as part of a larger AI push at the tech company. Users who prefer not to use ChatGT will be able to opt-out of the features, Business Insider previously reported.

    Phil Schiller, head of Apple's app store and former marketing chief, was picked for the board position, Bloomberg reported. Schiller will serve in an observer role, meaning he won't have voting powers, but he will be able to sit in on OpenAI meetings, giving Apple key insight into the inner workings of the AI company, according to the outlet.

    Neither Apple nor OpenAI immediately responded to a request for comment from Business Insider.

    "This would be a smart move for Cupertino given how important OpenAI is to the broader AI vision in Apple," Wedbush analyst Dan Ives told Business Insider.

    The arrangement, the details of which are still in flux, is set to start later this year, and Schiller has not attended any meetings yet, according to the Bloomberg report.

    Microsoft has long been OpenAI's largest backer and a key business partner, having invested billions of dollars into the AI company. Ahead of the Apple-OpenAI integration announcement, Microsoft CEO Satya Nadella met with OpenAI CEO Sam Altman to discuss concerns about the forthcoming Apple deal, The Information reported in May.

    However, the Apple-OpenAI partnership could ultimately benefit Microsoft, too, Venture Beat reported last month. The deal could offer Microsoft Trojan horse-like insight into Apple, one of its key competitors, and pave the way for friendlier relationships between the two rivals.

    It is not uncommon for board observers to leave meetings where sensitive information is being discussed — something Microsoft could ask Apple to do or vice versa, Bloomberg reported.

    The Apple partnership marked a massive win for OpenAI, coming at a key time for Altman after mounting scandals at the company, including a company coup, growing concerns about safe AI, and a brush-up with Scarlett Johansson over the use of her likeness.

    Read the original article on Business Insider
  • Top broker says Medibank shares could return 19% in FY25

    A man in a wheelchair stretches both arms into the air in success.

    Medibank Private Ltd (ASX: MPL) shares could be a candidate to produce solid returns in FY25 and perhaps beyond, according to a leading broker.

    The ASX healthcare share has seen its fair share of volatility, as shown on the chart below, as it was smashed by a cyberattack in October 2022 and then recovered from the fallout.

    One leading broker spies an opportunity with the leading Australian private health insurer.

    The company could deliver returns through both a rising share price and a growing dividend, according to UBS.

    Why UBS is excited about Medibank shares

    The broker’s positive view on the ASX healthcare share is based on the low ongoing claims inflation, which supports margins remaining in the 8% to 9% range.

    Medibank experienced claims inflation, meaning average claims per policy unit, of just 2% during the first half of FY24, compared to guidance of 2.6%. UBS noted FY24 guidance has been upgraded to 2.2% to 2.4%.

    The broker described the outcome as “positive” and said it demonstrated that the claims base had “several different gears”. UBS noted that claims remained below pre-COVID levels in psych, rehab, respiratory and prosthesis, which was funding higher claims inflation in private surgical.

    The broker also pointed out that the favourable claims outcome triggered another customer’s $215 million ‘giveback.

    UBS said the resident claims ratio improved by 0.4 percentage points compared to the prior corresponding period, while the private health insurance net margin rose by 0.1 percentage points to 8.1%.

    The broker forecasts that the private health insurance margin will remain “higher for longer” at above 8% between FY24 and FY26, which is a positive for Medibank shares.

    Some disappointments

    One negative for the ASX healthcare share was that its other costs were “disappointing”, with cost growth of 10.9%. There were several “unusual” items, including non-resident commissions increasing by more than 40%, resident commissions being fully expensed, business-as-usual cost inflation of around 5%, and IT security and payroll tax costs of $4 million.

    FY24 guidance costs of between $610 million to $615 million implied 4% to 6% cost growth in the second half of FY24, and this will be aided by a “small step-up in productivity gains.

    UBS also said policy numbers were “disappointing”, falling by 1,800 in the November and December period. The broker attributed this to a “more competitive environment recently”, requiring “greater retention activity”. UBS said the FY24 guidance of 1.2% to 1.5% policy growth appeared to be “optimistic”. The broker’s estimate is for 0.9% growth.

    Price target and dividend

    UBS has a price target of $4.20 on Medibank shares, which suggests a possible rise of 14%. The broker projects Medibank could pay an annual dividend per share of 18 cents, which translates into a fully franked dividend yield of 4.9%.

    Together, the capital growth and dividend could produce a total return of around 19% over the next year or so.

    The post Top broker says Medibank shares could return 19% in FY25 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Medibank Private Limited right now?

    Before you buy Medibank Private Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank Private Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Bell Potter names the best ASX retail stocks to buy in FY25

    Do you want some retail sector exposure for your investment portfolio?

    If you do, then it could be worth looking at the ASX retail stocks in this article.

    They have been named as best buys for the new financial year by analysts at Bell Potter. Let’s see what the broker is saying.

    What is the broker saying about ASX retail stocks?

    Firstly, Bell Potter explained what it is looking for in the sector right now. It said:

    We continue to look for retailers with differentiating customer value propositions and balance sheet strength and support names who may grow via market share expansion and have exposure to the customer categories who could benefit in the current consumer backdrop.

    One ASX retail stock that has been given the thumbs up is Premier Investments Limited (ASX: PMV). Bell Potter has a buy rating and $35.00 price target on the Smiggle and Peter Alexander owner’s shares.

    It believes the market is undervaluing its shares, especially given its demerger plans. It explains:

    PMV is currently trading on ~15x FY26e P/E (BPe) which we think is conservative given the value that we see emerging from the potential demerger of PMV’s two key brands, Smiggle and Peter Alexander which we believe are global roll-out worthy and highly profitable. We see further upside from the higher ownership PMV shareholders could receive in the Myer Group (MYR) given the potential to grow post MYR’s turnaround phase and synergies from merging with PMV’s apparel brands

    What else?

    Another ASX stock that has been tipped as a buy is youth fashion retailer Universal Store Holdings Ltd (ASX: UNI). The broker has a buy rating and $6.15 price target on its shares.

    Bell Potter is positive on the company’s outlook due to margin expansion opportunities and its store rollout. It said:

    Management execution remains a key strength for UNI and we see good growth trajectory for the name given the building of core brands while growing its store rollout. In our view, the higher margin sales from the majority private label sales should become a major driver of margin improvement and earnings growth, in an expanded store footprint. While we remain cautious on the overall consumer sentiment, given the return to positive comps while cycling elevated pcp through Jan-Feb (+1% for Universal Store and +10% for Perfect Stranger) and potential benefits from income tax cuts to the customer demographic, we think UNI is well placed given supportive 4Q comps.

    A final ASX retail stock to consider according to Bell Potter is Propel Funeral Partners Ltd (ASX: PFP). It has a buy rating and $6.20 price target on its shares. It said:

    While PFP remains to be one of the few listed deathcare players globally, we think the premium to the peer group PFP trades at is justified considering the current market position, M&A firepower/opportunity and successful track record.

    The post Bell Potter names the best ASX retail stocks to buy in FY25 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Propel Funeral Partners Limited right now?

    Before you buy Propel Funeral Partners Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Propel Funeral Partners Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has positions in Universal Store. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Should you buy Liontown shares after its update?

    Liontown Resources Ltd (ASX: LTR) shares were on fire on Tuesday.

    The lithium developer’s shares ended the day 7% higher at 95.5 cents.

    The catalyst for this was news that the company has secured a US$250 million convertible note (CN) investment and 10-year offtake extension from foundational partner, LG Energy Solution.

    Broker reaction

    Bell Potter was pleased with the news and highlights that the company is now funded to steady-state production. It said:

    The CN increases LTR’s cash liquidity by $129m; it replaces the $550m debt facility announced in March 2024, of which $300m was allocated to repay a debt facility with offtake partner Ford. LTR will now retain the $300m Ford debt facility which has a 5-year tenor and BBSW+1.5% rate. LTR reiterated that Kathleen Valley remains on schedule for first production by the end of July 2024. With the CN, LTR will have available cash of $501m and remaining capex of around $120m to first production. LTR expects the $381m balance to fund Kathleen Valley to steady-state production, even under current depressed lithium pricing.

    The broker was pleased with the agreement and feels it was the right thing for management to do. Its analysts add:

    The LG CN funding is a pragmatic solution to remove the onerous terms associated with traditional bank debt and increase the company’s cash liquidity headroom. LTR’s 100% owned Kathleen Valley lithium project remains highly strategic with initial production imminent, a long mine life and tier-one location. LTR has offtake contracts with top tier EV and battery OEMs (Ford, LG Energy Solution and Tesla). Under our modelled assumptions, we expect that LTR is fully funded to free cash flow.

    Should you buy Liontown shares?

    If you have a high tolerance for risk, then Bell Potter thinks you should be considering an investment in Liontown’s shares. Especially if you are looking for exposure to the lithium industry.

    In response to this update, the broker has reaffirmed its speculative buy rating and $1.85 price target on the lithium developer’s shares. Based on its current share price of 95.5 cents, this implies potential upside of almost 95% for investors over the next 12 months.

    To put that into context, a $5,000 investment could turn into approximately $9,750 by this time next year if Bell Potter is on the money with its recommendation.

    Though, the broker warns: “LTR is an asset development company; our Speculative risk rating recognises this higher level of risk.”

    The post Should you buy Liontown shares after its update? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Liontown Resources right now?

    Before you buy Liontown Resources shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Liontown Resources wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Brokers says these ASX 300 dividend shares are top buys

    There are a lot of ASX 300 dividend shares to choose from on the Australian share market.

    To narrow things down for income investors, I have picked out two that brokers have named as top buys recently.

    Let’s see what they are saying about these shares:

    Dexus Industria REIT (ASX: DXI)

    Over at Morgans, its analysts think that Dexus Industria could be an ASX 300 dividend share to buy this month. It is a real estate investment trust with a focus on industrial warehouses.

    The broker believes the industrial property company is well-placed due to solid demand, its development pipeline, and the positive rental growth outlook. It explains:

    The portfolio is valued at $1.6bn across +90 properties with 89% of the portfolio weighted towards industrial assets (WACR 5.38%). The portfolio’s WALE is around 6 years and occupancy 97.5%. Across the portfolio 50% of leases are linked to CPI with the balance on fixed increases between 3-3.5%. While we expect cap rates to expand further in the near term, DXI’s industrial portfolio remains robust with the outlook positive for rental growth. The development pipeline also provides near and medium-term upside potential and post asset sales there is balance sheet capacity to execute.

    In respect to income, the broker is forecasting dividends per share of 16.4 cents in FY 2024 and then 16.6 cents in FY 2025. Based on the current Dexus Industria share price of $2.84, this will mean dividend yields of 5.8% and 5.85%, respectively.

    Morgans has an add rating and $3.20 price target on its shares.

    Rural Funds Group (ASX: RFF)

    Analysts at Bell Potter think that Rural Funds could be an ASX 300 dividend share to buy. It is the owner of a portfolio of high-quality agricultural assets. This includes orchards, vineyards, water entitlements, cropping, and cattle farms.

    The broker believes that its shares are too cheap at current levels and sees this as a buying opportunity for income investors. It explains:

    RFF trades at a historical high discount to its market NAV per unit ($2.78 pu) at ~28%. While we are in general seeing large discounts to NAV in ASX listed farming and water assets to market NAV, the discount that RFF is trading appears excessive and we are seeing a valuable opportunity in RFF. While the timing of that value discount closing is difficult to call, investors are likely to be rewarded with a ~6% yield to hold the position until such a time as the asset class rerates. Furthermore, RFF aims to achieve income growth through productivity improvements, conversion of assets to higher and better use along with rental indexation which is built into all of its contracts with its tenants.

    As for dividends, Bell Potter is forecasting dividends per share of 11.7 cents in both FY 2024 and FY 2025. Based on the current Rural Funds share price of $2.00, this will mean yields of 5.85% for investors.

    The broker has a buy rating and $2.40 price target on its shares.

    The post Brokers says these ASX 300 dividend shares are top buys appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Dexus Industria Reit right now?

    Before you buy Dexus Industria Reit shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Dexus Industria Reit wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks
    *Returns as of 24 June 2024

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Rural Funds Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • After struggling to get pregnant, I have ‘next child’ anxiety

    Women holding and looking at newborn baby at hospital
    The author worries about what it will take to have another child, both financially and physically.

    • I was diagnosed with endometriosis and polycystic ovarian syndrome. 
    • I knew it would be complicated to get pregnant.
    • As soon as we had our first my husband and I started planning to have another baby. 

    A decade before I decided to have a baby, I was told that there would be complications.

    I was diagnosed with endometriosis and polycystic ovarian syndrome (PCOS), and my doctors were concerned about egg quality, anovulation, and other fertility issues. So when we did not get pregnant after a year, my husband and I began artificial reproductive treatment (ART).

    Even though my health insurance was exceptionally good and covered IVF with a few copays, the treatments failed over and over again. I experienced ovarian hyperstimulation syndrome (OHSS) and had to take weeks of bed rest to reduce the amount of fluid in my abdomen. This meant weeks out of work.

    Because of our insurance and extremely understanding and supportive employers, we did not have to worry about losing our jobs or accumulating medical debt. Nevertheless, we began to fear a reality where we did not have children.

    We switched clinics and I got pregnant

    Eventually, we decided to switch clinics after our first told us there was nothing left that they could do. At the new clinic, I had laparoscopic surgery to remove endometriosis lesions on my organs and to perform ovarian diathermy. The latter is a procedure during which your ovaries are lasered to lower your ovarian reserve with the hopes of the ovaries producing fewer but higher-quality eggs.

    Woman in hospital after fertility treatment
    The author worries about what it will take to have another child, both financially and physically.

    Two cycles later, as we waited on my period to begin egg retrieval three, I found out I was pregnant. Terrified and overjoyed, we cautiously navigated a surprisingly uncomplicated pregnancy. After nine long and anxious months, I had a whirlwind four-hour labor, and we met our son.

    But in the recovery room, my husband and I both began sharing anxieties about how we needed to structure our lives to have another child.

    I have anxiety about trying for another child

    I know this is not my reality alone. I have spoken with people in various support groups I have joined throughout my infertility and pregnancy journey about the next child anxiety.

    Next child anxiety is a fear of being retraumatized. It is a scale where we weigh the benefits of giving our child a sibling and the joys of having another child to love against the crushing reality of infertility and its treatments. It is figuring out how far you are willing to go into ART again and what the limits would look like. My surgery's effectiveness is typically two years, and over nine months have already been spent.

    As someone recently postpartum, it also feels unfair. My body has not been my own for two and a half years of treatment and nine months of pregnancy. But here I am, trying to plan.

    Then there is the career anxiety. Will we have infertility benefits? After my parental leave, I switched to remote work and lost the wonderful health insurance that had helped to change our lives. We have insurance now, but I am unsure how far it will go. I will always wonder if I left the chance to have another baby.

    In the infertility community, when you try to have a baby, you have to structure your entire life around this goal. It can mean a life of medical debt, moving to another state, or changing jobs or careers. And you are never guaranteed a child.

    The other day, I was thinking about my son in six years on vacation with us and an imagined sibling who would chase after him on the beach. But today I help him stack a tower of cups, watching his eyes dart in delight between me and the colorful toys. In a few months, I will call the clinic again and proceed on an uncertain path.

    Read the original article on Business Insider
  • Why Tesla stock continued to surge higher today

    A family drives along the road with smiles on their faces.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Reports of the demise of electric vehicle (EV) sales appear to have been exaggerated. At least that’s the conclusion that investors are drawing after Tesla (NASDAQ: TSLA) reported its second-quarter EV delivery numbers today.

    After the EV leader reported stronger-than-anticipated vehicle deliveries, Tesla shares led the S&P 500 gainers for the second straight day. As of 10:55 a.m. ET, the stock was up by 8.6% after jumping by more than 6% yesterday. Tesla stock was a beneficiary yesterday ahead of its report after several Chinese EV makers reported strong sales data. But there was even more to like than most anticipated from Tesla’s update today.

    Not just about EV sales

    Tesla delivered nearly 444,000 EVs in the second quarter. Investors had been reducing expectations throughout the period resulting in a consensus estimate of 439,000 units, according to FactSet. The reported figure was almost 5% lower than the year-ago period, but there were some positive facets of the report that investors may be focused on.

    In addition to beating estimates, the second quarter featured a drawdown in inventories as deliveries outpaced the 410,831 EVs it produced. A buildup of inventories due to lower perceived demand was a fear that helped drive Tesla’s share price down earlier this year. But the stock has now rebounded with a nearly 30% gain over just the last month.

    The good news from today’s report didn’t end there, either. The company noted a record 9.4 GWh (gigawatt hours) of energy storage products deployed in the three-month period. That more than doubled the previous record of 4.1 GWh reported in the first quarter.

    There’s been a surge in interest in energy storage products to smooth out power supply as renewable energy sources are installed for applications including growing data center construction.

    That surge in deployments bodes well for yet another source of revenue for Tesla. Investors will look for even more updates from the company when it reports full second-quarter financials on July 23 and provides an update on its self-driving technology on Aug. 8.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    The post Why Tesla stock continued to surge higher today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Tesla right now?

    Before you buy Tesla shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Tesla wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    See The 5 Stocks *Returns as of 24 June 2024

    More reading

    The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended FactSet Research Systems and Tesla. Howard Smith has positions in Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.